Icbiocro | Icbiocro

Coronavirus (Covid-19) vaccine latest update: Oxford-AstraZeneca vaccine production begins; US says 2 billion doses ‘ready to go’

by Icbio Cro | Jun 7, 2020 | Icbiocro | 0 |

Coronavirus (Covid-19) Vaccine Latest Update: AstraZeneca plans to roll out two billion doses of Covid-19 vaccine in September; human trials of Australian vaccine next month

Importance of Central Lab in Clinical Trials

by Icbio Cro | May 13, 2020 | Icbiocro | 0 |

With modern and advanced varieties of central laboratory proposals, a more thoughtful test...

Part of WHO’s Solidarity Trial, India Will Test 1,000 Doses of Remdesivir on Patients: Harsh Vardhan

by Icbio Cro | May 4, 2020 | Icbiocro | 0 |

Pharma giant Gilead’s antiviral drug Remdesivir has won US regulatory approval for emergency use...

Remdesivir will be available to coronavirus patients this week: Gilead CEO

by Icbio Cro | May 4, 2020 | Icbiocro | 0 |

Gilead Sciences has said that its antiviral drug, Remdesivir, will be available to patients as...

Fujifilm evaluates Avigan to treat Covid-19 in US

by Icbio Cro | May 4, 2020 | Icbiocro | 0 |

Japanese company Fujifilm has launched a Phase II clinical trial of its influenza drug Avigan...

Glenmark gets approval to trial favipiravir for Covid-19 in India

by Icbio Cro | May 4, 2020 | Icbiocro | 0 |

Glenmark Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) to evaluate antivirial drug favipiravir in clinical trials to treat patients with Covid-19. Favipiravir is a generic version of...